Show simple item record

dc.contributor.authorAdam, Isabell
dc.contributor.authorDewi, Dyah L.
dc.contributor.authorMooiweer, Joram
dc.contributor.authorSadik, Ahmed
dc.contributor.authorMohapatra, Soumya R.
dc.contributor.authorBerdel, Bianca
dc.contributor.authorKeil, Melanie
dc.contributor.authorSonner, Jana K.
dc.contributor.authorThedieck, Kathrin
dc.contributor.authorRose, Adam J.
dc.contributor.authorPlatten, Michael
dc.contributor.authorHeiland, Ines
dc.contributor.authorTrump, Saskia
dc.contributor.authorOpitz, Christiane A.
dc.date.accessioned2022-05-03T09:10:43Z
dc.date.available2022-05-03T09:10:43Z
dc.date.issued2018-09-05
dc.description.abstractTryptophan (Trp) metabolism is an important target in immuno-oncology as it represents a powerful immunosuppressive mechanism hijacked by tumors for protection against immune destruction. However, it remains unclear how tumor cells can proliferate while degrading the essential amino acid Trp. Trp is incorporated into proteins after it is attached to its tRNA by tryptophanyl-tRNA synthestases. As the tryptophanyl-tRNA synthestases compete for Trp with the Trp-catabolizing enzymes, the balance between these enzymes will determine whether Trp is used for protein synthesis or is degraded. In human cancers expression of the Trp-degrading enzymes indoleamine-2,3-dioxygenase-1 (IDO1) and tryptophan-2,3-dioxygenase (TDO2) was positively associated with the expression of the tryptophanyltRNA synthestase WARS. One mechanism underlying the association between IDO1 and WARS identified in this study is their joint induction by IFNγ released from tumor-infiltrating T cells. Moreover, we show here that IDO1- and TDO2-mediated Trp deprivation upregulates WARS expression by activating the general control non-derepressible-2 (GCN2) kinase, leading to phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α) and induction of activating transcription factor 4 (ATF4). Trp deprivation induced cytoplasmic WARS expression but did not increase nuclear or extracellular WARS levels. GCN2 protected the cells against the effects of Trp starvation and enabled them to quickly make use of Trp for proliferation once it was replenished. Computational modeling of Trp metabolism revealed that Trp deficiency shifted Trp flux towards WARS and protein synthesis. Our data therefore suggest that the upregulation of WARS via IFNγ and/or GCN2-peIF2α-ATF4 signaling protects Trp-degrading cancer cells from excessive intracellular Trp depletion.en_US
dc.identifier.citationAdam I, Dewi, Mooiweer, Sadik, Mohapatra, Berdel B, Keil, Sonner, Thedieck, Rose AJ, Platten M, Heiland I, Trump S, Opitz CA. Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation. Oncoimmunology. 2018;7(12):1-15en_US
dc.identifier.cristinIDFRIDAID 1655218
dc.identifier.doi10.1080/2162402X.2018.1486353
dc.identifier.issn2162-4011
dc.identifier.issn2162-402X
dc.identifier.urihttps://hdl.handle.net/10037/24980
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.relation.journalOncoimmunology
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2018 The Author(s)en_US
dc.titleUpregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradationen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record